Unknown

Dataset Information

Evaluation of Growth Hormone Therapy in Seven Chinese Children With Familial Short Stature Caused by Novel ACAN Variants.


ABSTRACT:

Objective

ACAN gene variants are an important cause of familial short stature (FSS). Appropriate growth-promoting therapies effectively improve the patient height. Here, we report a therapeutic assessment of cases of seven families of FSS patients with heterozygous ACAN variants. Our findings provide a valuable theoretical basis for the clinical diagnosis and treatment of this disease.

Methods

From December 2020 to June 2021, 32 FSS patients were examined in Tianjin Medical University General Hospital (Tianjin, China) by whole-exome sequencing to determine whether ACAN variants were present. Their clinical data were summarized and scrupulously analyzed.

Results

We found seven novel heterozygous ACAN variants: c.1051 + 2T > A, c.313T > C (p.

SUBMITTER: Sun J 

PROVIDER: S-EPMC8940281 | biostudies-literature | 2022

REPOSITORIES: biostudies-literature